Top

Published in:

01-11-2015 | Clinical Study

Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response

Authors: Daniel M. Trifiletti, Cheng-Chia Lee, William Winardi, Nirav V. Patel, Chun-Po Yen, James M. Larner, Jason P. Sheehan

Published in: Journal of Neuro-Oncology | Issue 2/2015

Abstract

The safety and efficacy of stereotactic radiosurgery (SRS) in the brainstem is questioned by some over concern of violating historical brainstem SRS dose tolerance. Our purpose was to report on the clinical outcomes of patients treated at our institution with radiosurgery for brainstem metastases. Patients with metastatic tumors within or directly abutting the brainstem from 1992 to 2014 were analyzed. Patient and tumor characteristics, SRS parameters, and toxicity were recorded and analyzed for associations with local control and survival. Multivariate statistical analysis was performed using Cox proportional hazards modeling. One-hundred and eighty-nine (189) brainstem metastases from 161 patients were included in our analysis. Whole brain irradiation was administered prior to SRS in 52 % of patients. The median margin dose was 18 Gy prescribed to the 50 % isodose line. Median imaging follow up was 5.4 months and median survival was 5.5 months after SRS. At last follow up, local control was achieved in 87.3 % of brainstem lesions treated. There were 3 recorded events of grade 3–5 toxicity (1.8 %). On multivariate analysis, a margin dose ≥16 Gy was associated with improved local control (p = 0.049) and greater KPS score was associated with improved overall survival following SRS (p = 0.024). Patients with brainstem metastases who have limited intracranial disease and/or who have received whole brain irradiation should be considered for SRS. Margin doses of at least 16 Gy are associated with superior local control, and serious radiation toxicity in SRS for brainstem metastasis appears rare.

Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494–500. doi:10.1056/nejm199002223220802 CrossRefPubMed

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672. doi:10.1016/s0140-6736(04)16250-8 CrossRefPubMed

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. doi:10.1016/S1470-2045(09)70263-3 CrossRefPubMed

Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47(2):291–298CrossRefPubMed

Sharma MS, Kondziolka D, Khan A, Kano H, Niranjan A, Flickinger JC, Lunsford LD (2008) Radiation tolerance limits of the brainstem. Neurosurgery 63(4):728–732. doi:10.1227/01.neu.0000325726.72815.22 (discussion 732–723) CrossRefPubMed

Mayo C, Yorke E, Merchant TE (2010) Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S36–S41. doi:10.1016/j.ijrobp.2009.08.078 PubMedCentralCrossRefPubMed

Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC (1993) Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 79(5):661–666. doi:10.3171/jns.1993.79.5.0661 CrossRefPubMed

Kased N, Huang K, Nakamura JL, Sahgal A, Larson DA, McDermott MW, Sneed PK (2008) Gamma Knife radiosurgery for brainstem metastases: the UCSF experience. J Neurooncol 86(2):195–205. doi:10.1007/s11060-007-9458-4 CrossRefPubMed

Koyfman SA, Tendulkar RD, Chao ST, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Reddy CA, Suh JH (2010) Stereotactic radiosurgery for single brainstem metastases: the Cleveland clinic experience. Int J Radiat Oncol Biol Phys 78(2):409–414. doi:10.1016/j.ijrobp.2009.07.1750 CrossRefPubMed

10.

Hatiboglu MA, Chang EL, Suki D, Sawaya R, Wildrick DM, Weinberg JS (2011) Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery. Neurosurgery 69(4):796–806. doi:10.1227/NEU.0b013e31821d31de (discussion 806) CrossRefPubMed

11.

Lin CS, Selch MT, Lee SP, Wu JK, Xiao F, Hong DS, Chen CH, Hussain A, Lee PP, De Salles AA (2012) Accelerator-based stereotactic radiosurgery for brainstem metastases. Neurosurgery 70(4):953–958. doi:10.1227/NEU.0b013e31823c40fe (discussion 958) CrossRefPubMed

12.

Kawabe T, Yamamoto M, Sato Y, Barfod BE, Urakawa Y, Kasuya H, Mineura K (2012) Gamma Knife surgery for patients with brainstem metastases. J Neurosurg 117(Suppl):23–30. doi:10.3171/2012.7.gks12977 PubMed

13.

Sengoz M, Kabalay IA, Tezcanli E, Peker S, Pamir N (2013) Treatment of brainstem metastases with Gamma-Knife radiosurgery. J Neurooncol 113(1):33–38. doi:10.1007/s11060-013-1086-6 CrossRefPubMed

14.

Peterson HE, Larson EW, Fairbanks RK, MacKay AR, Lamoreaux WT, Call JA, Carlson JD, Ling BC, Demakas JJ, Cooke BS, Peressini B, Lee CM (2014) Gamma Knife treatment of brainstem metastases. Int J Mol Sci 15(6):9748–9761. doi:10.3390/ijms15069748 PubMedCentralCrossRefPubMed

15.

Kilburn JM, Ellis TL, Lovato JF, Urbanic JJ, Daniel Bourland J, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD (2014) Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? J Neurooncol 117(1):167–174. doi:10.1007/s11060-014-1373-x PubMedCentralCrossRefPubMed

16.

Voong KR, Farnia B, Wang Q, Luo D, McAleer MF, Rao G, Guha-Thakurta N, Likhacheva A, Ghia AJ, Brown PD, Li J (2015) Gamma Knife stereotactic radiosurgery in the treatment of brainstem metastases: the MD Anderson experience. Neuro-Oncol Pract 2(1):40–47. doi:10.1093/nop/npu032 CrossRef

17.

Shuto T, Fujino H, Asada H, Inomori S, Nagano H (2003) Gamma knife radiosurgery for metastatic tumours in the brain stem. Acta Neurochir (Wien) 145(9):755–760. doi:10.1007/s00701-003-0034-1 CrossRef

18.

Lorenzoni JG, Devriendt D, Massager N, Desmedt F, Simon S, Van Houtte P, Brotchi J, Levivier M (2009) Brain stem metastases treated with radiosurgery: prognostic factors of survival and life expectancy estimation. Surgical Neurology 71(2):188–195. doi:10.1016/j.surneu.2008.01.029 (discussion 195, 195–186) CrossRefPubMed

19.

Leeman JE, Clump DA, Wegner RE, Heron DE, Burton SA, Mintz AH (2012) Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases. Radiat Oncol 7:107. doi:10.1186/1748-717x-7-107 PubMedCentralCrossRefPubMed

20.

Valery CA, Boskos C, Boisserie G, Lamproglou I, Cornu P, Mazeron JJ, Simon JM (2011) Minimized doses for linear accelerator radiosurgery of brainstem metastasis. Int J Radiat Oncol Biol Phys 80(2):362–368. doi:10.1016/j.ijrobp.2010.02.028 CrossRefPubMed

21.

Davidson L, Zada G, Yu C, Petrovich Z, Pagnini PG, Zee CS, Giannotta SL, Zelman V, Apuzzo ML (2009) Delayed toxicity from Gamma Knife radiosurgery to lesions in and adjacent to the brainstem. J Clin Neurosci 16(9):1139–1147. doi:10.1016/j.jocn.2009.03.003 CrossRefPubMed

22.

Yen CP, Sheehan J, Patterson G, Steiner L (2006) Gamma Knife surgery for metastatic brainstem tumors. J Neurosurg 105(2):213–219. doi:10.3171/jns.2006.105.2.213 CrossRefPubMed

23.

Snell JW, Sheehan J, Stroila M, Steiner L (2006) Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104(1):157–162. doi:10.3171/jns.2006.104.1.157 CrossRefPubMed

24.

US Department of Health and Human Services (2010) Common Terminology Criteria for Adverse Events (CTCAE) v4.03. 2014

25.

Huang CF, Kondziolka D, Flickinger JC, Lunsford LD (1999) Stereotactic radiosurgery for brainstem metastases. J Neurosurg 91(4):563–568. doi:10.3171/jns.1999.91.4.0563 CrossRefPubMed

26.

Yoo TW, Park ES, Kwon DH, Kim CJ (2011) Gamma Knife radiosurgery for brainstem metastasis. J Korean Neurosurg Soc 50(4):299–303. doi:10.3340/jkns.2011.50.4.299 PubMedCentralCrossRefPubMed

27.

Kelly PJ, Lin YB, Yu AY, Ropper AE, Nguyen PL, Marcus KJ, Hacker FL, Weiss SE (2011) Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana–Farber/Brigham and Women’s Cancer Center experience. J Neurooncol 104(2):553–557. doi:10.1007/s11060-010-0514-0 CrossRefPubMed

28.

Jung EW, Rakowski JT, Delly F, Jagannathan J, Konski AA, Guthikonda M, Kim H, Mittal S (2013) Gamma Knife radiosurgery in the management of brainstem metastases. Clin Neurol Neurosurg 115(10):2023–2028. doi:10.1016/j.clineuro.2013.06.012 CrossRefPubMed

29.

Uh J, Merchant TE, Li Y, Feng T, Gajjar A, Ogg RJ, Hua C (2013) Differences in brainstem fiber tract response to radiation: a longitudinal diffusion tensor imaging study. Int J Radiat Oncol Biol Phys 86(2):292–297. doi:10.1016/j.ijrobp.2013.01.028 PubMedCentralCrossRefPubMed

30.

Pantelis E, Papadakis N, Verigos K, Stathochristopoulou I, Antypas C, Lekas L, Tzouras A, Georgiou E, Salvaras N (2010) Integration of functional MRI and white matter tractography in stereotactic radiosurgery clinical practice. Int J Radiat Oncol Biol Phys 78(1):257–267. doi:10.1016/j.ijrobp.2009.10.064 CrossRefPubMed

Title: Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response
Authors: Daniel M. Trifiletti
Cheng-Chia Lee
William Winardi
Nirav V. Patel
Chun-Po Yen
James M. Larner
Jason P. Sheehan
Publication date: 01-11-2015
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2015
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-1927-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2015

Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients

Epidural extension of vertebral metastases is not an independent predictor of prognosis after therapy in breast cancer patients

Post-radiosurgical edema associated with parasagittal and parafalcine meningiomas: a multicenter study

MicroRNA as potential biomarkers in Glioblastoma

IDH1 mutation-associated long non-coding RNA expression profile changes in glioma

Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma